|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.81 USD | -1.19% |
|
-3.81% | -1.28% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.19% | -3.81% | -8.36% | +0.55% | -1.28% | +86.28% | +266.79% | +249.72% | -43.29% | 35.88B | |
| +0.86% | +1.43% | +6.06% | +35.30% | +11.29% | +47.17% | +161.40% | +389.88% | +1,358.93% | 1,067B | |
| +1.59% | +4.09% | +7.56% | +15.78% | +27.28% | +56.51% | +52.79% | +53.33% | +110.91% | 635B | |
| +0.95% | +1.91% | +6.67% | +30.52% | +13.51% | +36.30% | +83.13% | +119.44% | +303.23% | 458B | |
| +1.60% | +6.25% | +5.91% | +10.28% | +8.20% | +37.00% | +30.00% | +2.25% | +42.73% | 347B | |
| -0.60% | +1.52% | +0.71% | +11.61% | +15.78% | +36.67% | +39.80% | +50.05% | +54.38% | 295B | |
| -0.14% | +0.60% | -9.90% | -9.21% | -8.12% | +17.29% | +18.19% | +49.41% | +172.27% | 262B | |
| +0.09% | -2.82% | +1.57% | +23.33% | -1.43% | -29.09% | -41.29% | +12.31% | +73.06% | 216B | |
| +1.22% | +2.66% | +6.58% | +9.14% | +14.89% | +22.66% | +59.81% | +51.80% | +125.77% | 203B | |
| -1.18% | -3.70% | +4.42% | -0.84% | +5.35% | +11.28% | +67.43% | +87.35% | +46.03% | 161B | |
| -0.16% | -2.04% | +3.68% | -9.11% | -1.45% | -1.01% | -33.78% | -41.12% | -33.28% | 140B | |
| +0.94% | +2.22% | +12.10% | +5.76% | +15.11% | +28.21% | -2.63% | -9.15% | -17.83% | 127B | |
| +0.90% | -1.71% | -0.59% | +10.94% | +5.29% | +1.64% | +33.32% | +138.08% | +398.44% | 121B | |
| -0.43% | -1.69% | +3.08% | -5.06% | -8.09% | -10.67% | -22.12% | -13.67% | -0.63% | 104B | |
| +0.73% | +0.16% | -3.23% | -4.98% | +5.21% | +37.85% | +37.80% | +8.45% | -7.33% | 102B | |
| +2.83% | +1.24% | -1.57% | -16.16% | -10.03% | +1.02% | +85.77% | +79.69% | +471.19% | 74.54B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +2.60% | +3.07% | +11.75% | +5.87% | +16.81% | +30.53% | +29.16% | +52.24% | +23.70% | 55.09B | |
| -2.66% | +0.49% | +6.81% | -4.64% | -10.27% | -5.23% | +11.91% | -13.08% | +236.17% | 52.08B | |
| -0.30% | -4.95% | -2.00% | +19.64% | +24.45% | +57.69% | -10.96% | -10.04% | -50.27% | 51.52B | |
| Average | +0.38% | +0.15% | +2.70% | +6.78% | +6.45% | +24.32% | +45.61% | +66.16% | +171.80% | 228.48B | |
| Weighted average by Cap. | +0.69% | +1.43% | +4.18% | +16.12% | +10.52% | +32.19% | +67.22% | +130.04% | +414.69% |
- Stock Market
- Stocks
- TEVA Stock
- Sector Teva Pharmaceutical Industries Limited
Select your edition
All financial news and data tailored to specific country editions
